Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Xerox board seeks better terms from Fujifilm, will resume talks

Published 05/10/2018, 01:35 AM
Updated 05/10/2018, 01:35 AM
© Reuters. Logo of Xerox company is seen on building in Minsk

By Sonam Rai and Arjun Panchadar

(Reuters) - Xerox (NYSE:XRX) Corp's board said on Wednesday it intended to resume merger discussions with Fujifilm Holdings, seeking a superior deal to terms announced at the end of January that have spurred a proxy fight over the company.

Carl Icahn and Darwin Deason, who own 15 percent of Xerox, have been trying to unravel the deal and unlock more value out the company. Asserting the Fujifilm deal values Xerox at just $28 per share, they said this week they would consider an all-cash bid of at least $40 per share.

Analysts say the prolonged fight for Xerox could ultimately push higher any offer price from Fujifilm or other interested parties. Buyout firm Apollo Global Management LLC considered a bid for Xerox last week, sources have said.

Fujifilm said on Thursday it has not yet received a new proposal from Xerox and believes the current deal provides the best value for the shareholders of both firms.

"If we receive a new proposal, we will need to study whether it offers value to the shareholders of Fujifilm," it said in a statement.

The two companies in January agreed to a complex $6.1 billion deal that would merge Xerox into their Asia joint venture Fuji Xerox, which Fujifilm would control with a 50.1 percent stake. Xerox shareholders were also due to receive a $2.5 billion special cash dividend.

The firms have not, however, disclosed a per share valuation for Xerox for the deal.

UBS analysts estimated in February that the deal valued Xerox at $40 a share - $9.80 in cash for every Xerox share held and calculated the stake in the proposed new Fuji Xerox to be worth $30. That value mostly matches the current demands of the activist shareholders, except they want it all in cash.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Shannon Cross from Cross Research said an incremental five dollars plus benefit from synergies from the Fuji-Xerox deal should result over time in a value for Xerox stock that would be above the $40 per share.

"At the end of the day, Carl Icahn has always wanted more money for this deal, I am not sure that running the business is what he looks to do," said Cross.

While some Tokyo-based analysts say Fujifilm would be better off putting its money into its non-copier and printer businesses, others argue that the Japanese firm, which relies on the joint venture for nearly half of its revenue, should cede to the activist shareholders' demands.

Xerox had at one stage reopened talks on the deal with Fujifilm but those discussions were suspended after Deason won a temporary court order blocking the deal. The judge said, however, that Xerox was not prohibited from exploring other transactions with Fujifilm.

Xerox said on Wednesday that it will pursue an appeal of the lower court's ruling in the Deason lawsuit, which it believes "was wrongly decided and will be reversed".

Fujifilm is also pursuing an appeal.

Shares of Xerox closed 1.6 percent higher at $28.96 on Wednesday. Fujfilm's shares were flat in Thursday afternoon trade.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.